Pacific Biosciences of California (PACB)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q3 2021 | |||||
| ≡ | Viking Global Investors | Sell 100.00% | 1,273,659 | 0.14 | |
| Q1 2021 | |||||
| ≡ | Viking Global Investors | Reduce 81.23% | 1,269,580 | 0.13 | |
| Q4 2020 | |||||
| ≡ | Viking Global Investors | Reduce 65.41% | 2,955,708 | 0.21 | |
| Q3 2020 | |||||
| ≡ | Prem Watsa - Fairfax Financial Holdings | Sell 100.00% | 160,000 | 0.03 | |
| Q4 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 12,173,094 | 0.82 | |
| Q4 2017 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 1,142,477 | 1.03 | |
| Q3 2017 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 10.22% | 130,000 | 0.12 | |
| Q4 2016 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.24% | 21,789 | 0.00 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.